Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) has recently experienced significant negative changes in fundamentals: the consensus estimate for December, 2024 decreased significantly, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2025 decreased significantly.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) has recently experienced extremely meaningful negative changes in investment behavior: negative upside/downside volume developed, and the stock fell on very heavy volume.
The stock is currently unrated.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, IRWD is expected to be a major Value Eraser.
Ironwood Pharmaceuticals is currently unrated.
Recent Price Action
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) stock declined by -3.9% on 3/1/24. The shares closed at $9.06. Moreover, exceptionally high trading volume at 388% of normal accompanied the decline. The stock has been exceptionally strong relative to the market over the last nine months but has declined -39.0% during the last week.
Be the first to comment